CervoMed Inc. (CRVO)
NASDAQ: CRVO · IEX Real-Time Price · USD
23.30
+3.68 (18.76%)
At close: Mar 28, 2024, 4:00 PM
22.83
-0.47 (-2.02%)
After-hours: Mar 28, 2024, 7:10 PM EDT

CervoMed Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 2007
Selling, General & Admin
8.747.456.444.836.176.1911.092.524.767.33
Upgrade
Research & Development
7.248.59.436.625.755.097.253.882.860.34
Upgrade
Other Operating Expenses
08.730.10.17.040.070.030.016.992.05
Upgrade
Operating Expenses
15.9724.6815.9711.5518.9611.3518.376.4114.619.73
Upgrade
Operating Income
-15.97-24.68-15.97-11.55-18.96-11.35-18.37-6.41-14.61-9.73
Upgrade
Interest Expense / Income
0000-0.150.050.030.310.270.13
Upgrade
Other Expense / Income
-0.38-0.14-0.11-0.09--8.98--2.28-7.22
Upgrade
Pretax Income
-15.59-24.54-15.86-11.47-18.81-2.42-18.4-6.72-17.17-2.64
Upgrade
Income Tax
0-0.44-1.680.33-0.44-1.06-0.360-2.820
Upgrade
Net Income
-15.59-24.1-14.19-11.8-18.37-1.36-18.04-6.72-14.35-2.64
Upgrade
Preferred Dividends
001.9508.251.250000.17
Upgrade
Net Income Common
-15.59-24.1-16.14-11.8-26.62-2.62-18.04-6.72-14.35-2.81
Upgrade
Shares Outstanding (Basic)
1110000000
Upgrade
Shares Outstanding (Diluted)
1110000000
Upgrade
Shares Change
4.73%80.83%702.68%106.84%282.30%24.32%290.55%83.24%440.85%135.00%
Upgrade
EPS (Basic)
-11.47-18.57-22.50-132.00-615.75-237.00-1980.00-2880.00-11250.00-11250.00
Upgrade
EPS (Diluted)
-11.47-18.57-22.50-132.00-615.75-2183.25-1980.00-2880.00-11250.00-11250.00
Upgrade
Free Cash Flow
-14.97-14.5-13.55-9.86-10.77-12.78-10.77-5.23-9.08-1.18
Upgrade
Free Cash Flow Per Share
-11.01-11.17-18.88-110.25-249.19-1158.22-1184.13-2243.87-7144.44-5035.54
Upgrade
EBITDA
-15.59-24.45-15.76-11.37-18.85-2.3-18.35-6.4-16.33-2.39
Upgrade
Depreciation & Amortization
00.090.10.10.110.070.030.010.570.12
Upgrade
EBIT
-15.59-24.54-15.86-11.47-18.96-2.37-18.37-6.41-16.9-2.51
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).